Evidence map›Paper›PMID 35389266›Full record

ArticleJournal of virology2022

Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.

Ji Xi, Xiuji Cui, Kuancheng Liu, Haitao Liu, Joseph Wang, Jianming Hu

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Hepatitis B Virus Nucleocapsid Assembly.Journal of molecular biology · 2025
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ji XiDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.
Xiuji CuiDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.
Kuancheng LiuDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.
Haitao LiuDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.
Joseph WangDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.
Jianming HuDepartment of Microbiology and Immunology, The Pennsylvania State Universitygrid.29857.31 College of Medicine, Hershey, Pennsylvania, USA.ORCID 0000-0002-3967-2133
Pennsylvania State University · US

Funding

Mechanisms of Hepadnavirus Assembly and ReplicationR37AI043453 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Jianming Hu · 2018 to 2026
$3.8M
Dissecting Structural Details of Hepadnavirus Subviral ParticlesR21AI164119 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WANG, CHE-YEN · 2021 to 2022
$446k
NIAID NIH HHS R21 AI164119NIAID NIH HHS R37 AI043453
6 · The paper itself

Abstract

Hepatitis B virus (HBV) contains a partially double-stranded, relaxed circular (RC) DNA genome synthesized within a nucleocapsid (NC) in the host cell cytoplasm. The release of RC DNA from the NC, in an ill-defined process called uncoating, to the nucleus is required for its conversion to the covalently closed circular (CCC) DNA, the viral episome serving as the transcriptional template for all viral RNAs necessary for replication and, thus, essential for establishing and sustaining viral infection. In efforts to better understand uncoating, we analyzed HBV core (HBc) mutants that show various levels of nuclear CCC DNA but little to no cytoplasmic RC DNA. We found that RC DNA could be synthesized by these mutants outside the cell, but in contrast to the wild type (wt), the mutant NCs were unable to protect RC DNA from digestion by the endogenous nuclease(s) in cellular lysates or exogenous DNase. Subcellular fractionation suggested that the major RC DNA-degrading activity was membrane associated. Digestion with sequence-specific and nonspecific DNases revealed the exposure of specific regions of RC DNA from the mutant NC. Similarly, treatment of wt NCs with a core inhibitor known to increase CCC DNA by affecting uncoating also led to region-specific exposure of RC DNA. Furthermore, a subpopulation of untreated wild type (wt) mature NCs showed site-specific exposure of RC DNA as well. Competition between RC DNA degradation and its conversion to CCC DNA during NC uncoating thus likely plays an important role in the establishment and persistence of HBV infection and has implications for the development of capsid-targeted antivirals.

Indexed as

Hepatitis BViruses, UnclassifiedAntiviral AgentsCapsidCapsid ProteinsCell LineDNA, CircularDNA, ViralHepatitis B virusHumansNucleocapsidVirus ReplicationAntiviral AgentsCapsid ProteinsDNA, CircularDNA, ViralantiviralcapsidcccDNACCC DNAcovalently closed circular DNAhepadnavirushepatitis B virusnucleasenucleocapsiduncoating

Identifiers

PMID35389266
PMCPMC9044944
OpenAlexW4225001142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.